ORIGINAL ARTICLE
Year : 2021 | Volume
: 28 | Issue : 3 | Page : 143--150
The ahmed versus Baerveldt study at King Khaled Eye Specialist Hospital: Three-year treatment outcomes
Nouf Abdulkalq Alzendi1, Sami Alshahwan2, Areej Alwehaib3, Khawlah Alzaben1, Sara Alhilali4, Abeer Alkahtani5
1 Glaucoma Division, Department of Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
2 Glaucoma Division, Department of Ophthalmology; Department of Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
3 Anterior Segment Division, Department of Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
4 Department of General, College of Medicine, King Saud University, Riyadh, Saudi Arabia
5 Department of General, College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia
Correspondence Address:
Dr. Nouf Abdulkalq Alzendi
King Khaled Eye Specialist Hospital, Riyadh 11462
Saudi Arabia
PURPOSE: The purpose of this study was to analyze the outcomes of two frequently used surgical valves in treating refractory glaucoma.
METHODS: This was a retrospective and nonrandomized study comparing patients aged 18 years or older who underwent implantation using standardized surgical techniques.
RESULTS: A total of 86 patients were included in the study, 48 in the Ahmed group and 38 in the Baerveldt group. The overall success rate was 63.1% in both the groups. At the 3-year follow-up, the Ahmed group had a mean intraocular pressure (IOP) of 14.0 ± 4.8 mmHg (60% reduction) compared with 15.8 ± 6.2 mmHg (53.3% reduction) in the Baerveldt group (0.536). The Ahmed group required an average of 1.6 ± 1.3 medications (59% reduction) compared with 2.1 ± 1.7 (40% reduction) in the Baerveldt group (P < 0.001).
CONCLUSION: Despite a high failure rate, both devices were effective in lowering IOP and the need for medications. Lower IOP and medications were needed in the Ahmed group.
How to cite this article:
Alzendi NA, Alshahwan S, Alwehaib A, Alzaben K, Alhilali S, Alkahtani A. The ahmed versus Baerveldt study at King Khaled Eye Specialist Hospital: Three-year treatment outcomes.Middle East Afr J Ophthalmol 2021;28:143-150
|
How to cite this URL:
Alzendi NA, Alshahwan S, Alwehaib A, Alzaben K, Alhilali S, Alkahtani A. The ahmed versus Baerveldt study at King Khaled Eye Specialist Hospital: Three-year treatment outcomes. Middle East Afr J Ophthalmol [serial online] 2021 [cited 2022 May 23 ];28:143-150
Available from: http://www.meajo.org/article.asp?issn=0974-9233;year=2021;volume=28;issue=3;spage=143;epage=150;aulast=Alzendi;type=0 |
|
|
|
